1/2 catheter-directed therapy for chronic DVT (c-tract trial)

Ended Cooperative Agreement Awarded Last action

Award ID
UH3HL138325
Recipient
Awarding agency
Obligated
$14,979,502

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $13,291,149.00 Federal
  • $1,688,353.00 Non-federal
Place of performance
Missouri, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $1,213,638 $0
Amendment $1,522,853 $0
Amendment $1,522,853 $0
Amendment $1,688,353 $0
Amendment $1,688,353 $0
Amendment $1,688,353 $1,688,353
Amendment $0 $0
Amendment $1,876,466 $0
Amendment $247,112 $0
Amendment $0 $0
Original award $1,843,168 $0
Show all 13

Subawards

Subrecipient Amount Awarded
Regents Of The University Of Minnesota North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2) NIH Grant 5U19AG071754-04 Statement of Work Period 4 (May 1, 2025 – April 30, 2026)… $156,096
Emory University North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2) NIH Grant 5U19AG071754-04 Statement of Work Period 4 (May 1, 2025 – April 30, 2026)… $144,864
The Research Institute Of The Mcgill University Health Centre North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2) NIH Grant 5U19AG071754-04 Statement of Work Period 4 (May 1, 2025 – April 30, 2026)… $176,040
Mayo Clinic North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2) NIH Grant 5U19AG071754-04 Statement of Work Period 4 (May 1, 2025 – April 30, 2026)… $439,681
Oregon Health & Science University North American Prodromal Synucleinopathy Consortium for RBD, Stage 2 (NAPS2) NIH Grant 5U19AG071754 - 04 Statement of Work Period 4 (May 1, 2025 – April 30,… $389,751
ST. Joseph Hospital Of Orange CTRACT Trial - NIH Supported Milestone Payments As a participating site for CTRACT, each site will participate in a Phase III, multicenter, randomized… $0
Rector & Visitors Of The University Of Virginia $0
The Regents Of The University Of California. San Francisco As a participating site for CTRACT, each site will participate in a Phase III, multicenter, randomized controlled trial to determine if endovascular therapy… $0
ST. Joseph Hospital Of Orange $0
Mayo Clinic $0
Weill Medical College Of Cornell University Dr. Akhilesh Sista will serve as a Steering Committee member and Co-Chair of the Interventions Committee for the C-TRACT Study. He will work w/Dr. Vedantham &… $12,365
University Of North Carolina At Chapel Hill As a participating site for CTRACT, each site will participate in a Phase III, multicenter, randomized controlled trial to determine if endovascular therapy… $0
Saint Luke's Hospital Of Kansas City Dr. Magnuson will be responsible for overseeing all aspects of the health economicstudy for the C-TRACT Trial. Under her oversight, the Health Economic Core… $59,573
The University Of Chicago As a participating site for CTRACT, each site will participate in a Phase III, multicenter, randomized controlled trial to determine if endovascular therapy… $0
Northwestern University $0
The General Hospital Corporation Dr. Kalva will serve as the Safety Officer for the C-TRACT Trial. In this role, he will provide his consultative expertise in interventional radiology, venous… $9,887
Yale Univ As a participating site for CTRACT, each site will participate in a Phase III, multicenter, randomized controlled trial to determine if endovascular therapy… $0
The Toledo Hospital $0
The Medical College Of Wisconsin, Inc. $0
Rector & Visitors Of The University Of Virginia $0
Endeavor Health Clinical Operations $0
University Of Mississippi Medical Center $0
New York University $0
Thomas Jefferson University $0
Gundersen Lutheran Medical Foundation, Inc. $0
Christiana Care Health Services Inc. $0
Champlain Valley Physicians Hospital Medical Center $0
Weill Medical College Of Cornell University $0
Gundersen Lutheran Medical Foundation, Inc. CTRACT Trial - NIH Supported Milestone Payments As a participating site for CTRACT, each site will participate in a Phase III, multicenter, randomized… $6,420
The General Hospital Corporation Scope of Work Dr. Weinberg will be principal investigator of the vascular ultrasound core laboratory (VUCL), which is based at VasCore at the Massachusetts… $100,475
The General Hospital Corporation Statement of Work - Kalva Dr. Kalva will serve as the Safety Officer for the C-TRACT Trial. In this role, he will provide his consultative expertise in… $9,451
Weill Medical College Of Cornell University Weill Medical College of Cornell Univesity Scope of Work Dr. Akhilesh Sista will serve as a Steering Committee member and Co-Chair of the Interventions… $23,638
Saint Luke's Hospital Of Kansas City Scope of Work Dr. Elizabeth Magnuson will be responsible for overseeing all aspects of the health economic study for the C-TRACT Trial. Under her oversight, the… $216,928
ST. Joseph Hospital Of Orange CTRACT Trial - NIH Supported Milestone Payments As a participating site for CTRACT, each site will participate in a Phase III, multicenter, randomized… $0
Brigham & Womens Hospital Inc. Scope of Work Dr. Goldhaber serves as a member of the Steering Committee of the C-TRACT Study, which has ultimate responsibility for the direction of all phases… $24,868
University Of North Carolina At Chapel Hill PI to serve as Steering Committee member & Co-Chair of the Venous Ulcer Committee; his tasks comport w/those appointments. $22,439
Saint Louis University The site will participate in a Phase III, multicenter, randomized, controlled trial to determine if endovascular therapy (EVT) reduces disability from post… $0
Christiana Care Health Services Inc. $0
Weill Medical College Of Cornell University $0
New York University $0
Rush University Medical Center $0
Rector & Visitors Of The University Of Virginia $0
University Of Pittsburgh - Of The Commonwealth System Of Higher Education $0
Trustees Of Indiana University $0
Thomas Jefferson University $0
University Of Mississippi Medical Center $0
Northwestern University $0
The Toledo Hospital $0
Yale Univ $0
The University Of Chicago $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Quick answers

Who received award UH3HL138325?

UH3HL138325 was awarded to The Washington University by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2017.

How much is award UH3HL138325 worth?

$14,979,502 has been obligated on UH3HL138325: $13,291,149 in federal funding and $1,688,353 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login